Inmed Pharmaceuticals Inc. · NASDAQ:INM

Squadron Capital Management LLC reported a 9.80% stake in Inmed Pharmaceuticals Inc. (Schedule 13G)

Event May 19, 2026 · Filed May 27, 2026

Squadron Capital Management LLC reported a 9.80% stake in Inmed Pharmaceuticals Inc., 325,000 shares, as a passive investor on May 19, 2026. Filed May 27, 2026 (Schedule 13G).

Stake
9.80%
Shares
325,000
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Squadron Master Fund LP9.80%325,000
Squadron Capital Management LLC9.80%325,000
Matthew Sesterhenn9.80%325,000
William Blank9.80%325,000

Source

View original at SEC

Related